Obesity Clinical Trial
Official title:
Helping Moms to be Healthy After Baby
Verified date | March 2020 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Low-income and minority women are at increased risk for postpartum weight retention (i.e.
retaining weight after pregnancy) and consequent persistent obesity. Women who are obese
pre-pregnancy are 3-5 times more likely to gain weight, rather than lose weight, in the
postpartum period than non-obese women. Aims for this pilot study are listed below:
Aim 1: To evaluate the feasibility and acceptability of a multi-component novel weight loss
intervention delivered in a WIC setting to a population of low-income, predominantly
racial/ethnic minority, obese, postpartum women.
Aim 2: To evaluate differences in weight change, diet, physical activity, self-efficacy,
readiness to change, motivations to eat between intervention and control participants to
determine preliminary intervention efficacy over a 12-week period.
Status | Completed |
Enrollment | 42 |
Est. completion date | February 22, 2018 |
Est. primary completion date | February 22, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Adult woman (=18 and <50 years old). - Enrolled in WIC or with an infant enrolled in WIC. - 3-12 months postpartum. - A pre-pregnancy BMI of 25 - 40 kg/m2 (based on self-reported height and weight prior to pregnancy). - Postpartum body mass index between 25 and 50 kg/m2. - English- and/or Spanish-speaking. - Owns a mobile phone with texting functionality in order to receive texts during the trial. Exclusion Criteria: - Health conditions impacting weight or ability to participate in a weight loss trial. - Pregnancy or planned pregnancy in next 5 months. - Any health problems or undergoing any treatments that might interfere with what participant eats or her ability to exercise. - Medical provider recommendation to avoid exercise. - Plans to be in a different geographic area within the next 5 months. - Plans to stop coming to Aurora WIC in the next 5 months. - Unable to give informed consent. - Not able to read and understand English or Spanish at an 8th grade level. - Not willing to create a Facebook account if they do not already have one. - Asked to follow-up in < 3 months at most recent WIC visit. |
Country | Name | City | State |
---|---|---|---|
United States | Aurora WIC Office | Aurora | Colorado |
United States | University of Colorado | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver | Colorado Clinical & Translational Sciences Institute, National Center for Advancing Translational Science (NCATS) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of Recruitment | The investigators plan to determine the feasibility of recruitment for a weight loss intervention by evaluating the rate of recruitment. Below describes number recruited/enrolled over 14 weeks of recruitment | Once the final participant is recruited | |
Primary | Attrition Rate of Subjects Enrolled in the Study | The investigators will measure the number of dropouts/withdrawn once final participant has completed the 12 week visit. | Once the final participant completes the 12 week visit | |
Primary | Visit Attendance | The investigators will measure lifestyle group participant attendance from enrollment through the 12-week visit. The number of participants who attended their visits is reported | Baseline through Week 12, reported at Week 12 | |
Primary | Acceptability of a Weight Loss Intervention | To determine acceptability, investigators will use qualitative interviews to ask open-ended questions on this topic including asking participants in the intervention whether they would participate again. The number of participants interviewed who indicated that they would participate again is reported. | 12 weeks | |
Primary | Evaluation of the Use of Phone Coaching | Investigators will count the total number of times any participant used phone coaching. | 12 weeks | |
Secondary | Change in Weight Between Visits | To determine differences in change in weight between the intervention and control groups, participants will be weighed on a scale in the Women, Infants, and Children (WIC) setting. | Intervention group: Baseline, 12 weeks; Control group: Baseline and 12 weeks | |
Secondary | Changes in Diet: Intakes Measured in Grams | To determine differences in diet from baseline to 12 weeks between intervention and control groups, participants will complete the Block Fat-Sugar-Fruit-Vegetable Screener. This is a validated food screener for adults. | Baseline and 12 weeks | |
Secondary | Changes in Physical Activity | To determine differences in total physical activity from baseline to 12 weeks between intervention and control groups, participants will complete an adapted version of the Pregnancy Physical Activity Questionnaire. This is a validated survey measure for physical activity. | Baseline and 12 weeks | |
Secondary | Changes in Diet and Physical Activity Self-efficacy | To determine differences in self-efficacy from baseline to 12 weeks between intervention and control groups, participants will complete an adapted version of Eating Habits Confidence Survey and Exercise Confidence Survey. Diet self-efficacy: Possible range: -32 to 32; Higher scores indicate improved self-efficacy. Physical activity self-efficacy: Sticking to it scale: Possible range: -32 to 32; Higher scores indicate improved self-efficacy. Making time scale: -12 to 12; Higher scores indicate improved self-efficacy. |
Baseline and 12 weeks | |
Secondary | Changes in Motivations to Eat | To determine differences from baseline to12 weeks in motivations to eat between intervention and control groups, participants will complete the Eating Stimulus Index questionnaire. Possible range = -92 to 92. Higher scores indicated improved lifestyle-related behaviors and motivations to eat. |
Baseline and 12 weeks | |
Secondary | Changes in Readiness to Change | Investigators will evaluate any differences in readiness to change from baseline to 12 weeks between intervention and control groups by participants completing the Readiness to Change questionnaire. Possible range = -3 to 3; higher scores indicate greater change in readiness to change | Baseline and 12 weeks | |
Secondary | Changes in Diet: Intakes Measured in Cups | To determine differences in diet from baseline to 12 weeks between intervention and control groups, participants will complete the Block Fat-Sugar-Fruit-Vegetable Screener. This is a validated food screener for adults. Fruit and vegetable intake changes are measured and reported in cups. | Baseline and 12 weeks | |
Secondary | Changes in Diet: kCal Intake | To determine differences in diet from baseline to 12 weeks between intervention and control groups, participants will complete the Block Fat-Sugar-Fruit-Vegetable Screener. This is a validated food screener for adults. | Baseline and 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |